Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis
- 16 June 2021
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (5), 748-769
- https://doi.org/10.1111/bph.15591
Abstract
Diabetes is a chronic metabolic disorder associated with the accelerated development of macrovascular (atherosclerosis, coronary artery disease) and microvascular complications (nephropathy, retinopathy and neuropathy), which remain the principal cause of mortality and morbidity in this population. Current understanding of cellular and molecular pathways of diabetes-driven vascular complications as well as therapeutic interventions have arisen from studying disease pathogenesis in animal models. Diabetes-associated vascular complications are multi-faceted, involving the interaction between various cellular and molecular pathways. Thus, the choice of an appropriate animal model to study vascular pathogenesis is important in our quest to identify innovative and mechanism-based targeted therapies to reduce the burden of diabetic complications. Herein, we provide up-to-date information on available mouse models of both Type 1 and Type 2 diabetic vascular complications as well as experimental analysis and research outputs.Funding Information
- National Health and Medical Research Council
This publication has 144 references indexed in Scilit:
- Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient miceLipids in Health and Disease, 2012
- Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammalsDisease Models & Mechanisms, 2012
- Accelerated Atherosclerosis in
Apoe
−/−
Mice Heterozygous for the Insulin Receptor and the Insulin Receptor Substrate-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Targeting Endothelial Dysfunction in Vascular Complications Associated with DiabetesInternational Journal of Vascular Medicine, 2011
- Hyperglycemic Ins2AkitaLdlr−/− mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular diseaseJournal of Lipid Research, 2011
- Spontaneously diabetic Ins2+/Akita:apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosisAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Microscopic Computed Tomography–Based Virtual Histology for Visualization and Morphometry of Atherosclerosis in Diabetic Apolipoprotein E Mutant MiceCirculation, 2009
- Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.JCI Insight, 1995